Tend Health is a company that focuses on developing fecal microbiota transplant solutions aimed at restoring patients' healthy intestinal microbiomes. Based in Seattle, Washington, the company offers clinicians a non-invasive method to enhance gut health through innovative devices that process stool samples into capsules or suppositories. Founded in 2020, Tend Health emphasizes personalized data and insights, enabling patients to take control of their gastrointestinal well-being.
HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.
Healionics Corporation, based in Seattle, Washington, specializes in the development and manufacture of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created the STARport HD, an implantable device that enables needle-free bloodstream access for hemodialysis, and the STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without the complications associated with traditional grafts. Healionics' innovative approach addresses critical challenges in dialysis treatment, such as the high costs and health risks associated with current vascular access methods. Their technology promises to enhance patient outcomes by reducing the need for costly interventions and minimizing complications like infection and scarring. With a robust patent portfolio and successful results from animal studies, Healionics is poised to begin human trials and further develop its product line, which includes additional applications for its STAR biomaterial in various medical devices.
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound medical devices for diagnosing middle ear infections, known as otitis media, in both children and adults. The company's innovative hand-held device enables clinicians to quickly and accurately distinguish between viral and bacterial infections, facilitating appropriate treatment decisions regarding antibiotic use. Utilizing ultrasound technology in a novel manner, the device offers rapid diagnostic results in seconds, making it user-friendly for both physicians and non-physician healthcare providers. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies aims to improve the efficiency and accuracy of middle ear infection diagnosis.
KitoTech Medical is a medical device company based in Seattle, Washington, focused on developing and commercializing innovative products for wound closure and care. The company's flagship product, microMend, features a unique design that incorporates tiny Microstaples on an adhesive backing, resembling a butterfly bandage. This product is painless to apply and offers the holding strength of traditional sutures, making it suitable for closing surgical incisions and lacerations. Clinical studies indicate that microMend outperforms sutures in various clinical outcomes, including cosmetic results, and can be applied more quickly by a range of medical personnel, resulting in significant cost savings. microMend is marketed across numerous surgical specialties, as well as in dermatology and emergency medicine, with additional commercialization efforts targeting military applications. The potential market for microMend is substantial, estimated at over $600 million in the U.S. and around $2 billion globally. KitoTech Medical was founded in 2011.
Kineta, Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing immunology-based therapies targeting oncology, neuroscience, and virology. The company is advancing several innovative treatments, including KCP-506, a non-opioid therapeutic for chronic pain, and LHF-535, an oral antiviral for Lassa and other arenaviruses, which works by inhibiting viral entry and replication. Additionally, Kineta is exploring RIG-I and VISTA drug development programs aimed at reprogramming the immune system to combat cancer. Founded in 2007, Kineta has established strategic partnerships with major pharmaceutical firms to enhance its research and development efforts.
StormSensor, Inc. is a Seattle-based company that specializes in stormwater management solutions aimed at helping clients monitor and mitigate flooding, sewage overflows, and other stormwater-related issues. Founded in 2015, the company offers Scute sensors that provide real-time tracking of conditions within stormwater systems. Its cloud-based software, Terrapin, enables users to access map and time-series data, correlate real-time weather information, and receive alerts regarding flow events affecting the system. Additionally, StormSensor's solutions automate workflow for inspections and reporting, allowing clients to streamline the monitoring of stormwater quality and maintain compliance amidst evolving regulatory requirements. The technology is compatible with smartphones and tablets, facilitating data visualization and efficient communication among partners.
HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.
Kineta, Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing immunology-based therapies targeting oncology, neuroscience, and virology. The company is advancing several innovative treatments, including KCP-506, a non-opioid therapeutic for chronic pain, and LHF-535, an oral antiviral for Lassa and other arenaviruses, which works by inhibiting viral entry and replication. Additionally, Kineta is exploring RIG-I and VISTA drug development programs aimed at reprogramming the immune system to combat cancer. Founded in 2007, Kineta has established strategic partnerships with major pharmaceutical firms to enhance its research and development efforts.
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound medical devices for diagnosing middle ear infections, known as otitis media, in both children and adults. The company's innovative hand-held device enables clinicians to quickly and accurately distinguish between viral and bacterial infections, facilitating appropriate treatment decisions regarding antibiotic use. Utilizing ultrasound technology in a novel manner, the device offers rapid diagnostic results in seconds, making it user-friendly for both physicians and non-physician healthcare providers. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies aims to improve the efficiency and accuracy of middle ear infection diagnosis.
Healionics Corporation, based in Seattle, Washington, specializes in the development and manufacture of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created the STARport HD, an implantable device that enables needle-free bloodstream access for hemodialysis, and the STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without the complications associated with traditional grafts. Healionics' innovative approach addresses critical challenges in dialysis treatment, such as the high costs and health risks associated with current vascular access methods. Their technology promises to enhance patient outcomes by reducing the need for costly interventions and minimizing complications like infection and scarring. With a robust patent portfolio and successful results from animal studies, Healionics is poised to begin human trials and further develop its product line, which includes additional applications for its STAR biomaterial in various medical devices.
Kineta, Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing immunology-based therapies targeting oncology, neuroscience, and virology. The company is advancing several innovative treatments, including KCP-506, a non-opioid therapeutic for chronic pain, and LHF-535, an oral antiviral for Lassa and other arenaviruses, which works by inhibiting viral entry and replication. Additionally, Kineta is exploring RIG-I and VISTA drug development programs aimed at reprogramming the immune system to combat cancer. Founded in 2007, Kineta has established strategic partnerships with major pharmaceutical firms to enhance its research and development efforts.
Beta Hatch grows insect protein for animal feed. Nutrient balanced fertilizer is a sterile by-product of their process. Beta Hatch knows bugs better than anyone- they use their expertise in entomology to grow the most efficient and nutritious insects. They are currently farming mealworms from their urban farm in Seattle. They believe in changing food systems. Their goal is to develop the technology and knowledge that will make insects the next commodity crop.
Private Equity Round in 2017
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound medical devices for diagnosing middle ear infections, known as otitis media, in both children and adults. The company's innovative hand-held device enables clinicians to quickly and accurately distinguish between viral and bacterial infections, facilitating appropriate treatment decisions regarding antibiotic use. Utilizing ultrasound technology in a novel manner, the device offers rapid diagnostic results in seconds, making it user-friendly for both physicians and non-physician healthcare providers. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies aims to improve the efficiency and accuracy of middle ear infection diagnosis.
Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, that focuses on enhancing cancer surgery through innovative technologies. Founded in 2010, the company develops tumor paint products, including its lead candidate, BLZ-100, which combines a targeting peptide with a fluorescent dye. This product enables real-time visualization of cancer cells during surgery, allowing surgeons to differentiate between tumors and healthy tissue more effectively. The technology is applicable to various solid tumor types, including brain, breast, prostate, lung, colorectal, skin, and sarcomas. By improving the detection of cancer cells, Blaze Bioscience aims to facilitate more precise surgical resections and ultimately enhance patient outcomes.
Phytelligence, Inc. is an agricultural biotechnology company that specializes in growing and providing high-quality plants and innovative solutions for growers, nurseries, and horticultural experts. Founded in 2012 and based in Pullman, Washington, the company offers a range of tissue-cultured plantlets, including varieties of pear, apple, cherry, grape, and strawberry, all free from diseases, viruses, and pests. Phytelligence also provides custom genetic analysis services to evaluate the genetic similarities and differences among closely related plant samples. Its advanced propagation and quality control processes ensure that clients receive genetically confirmed plants that are healthy and ready for planting, ultimately enhancing productivity and quality in crop production.
Resonance AI specializes in the fields of artificial intelligence, analytics, and video streaming. Using advanced machine learning available, Resonance AI’s unmatched efficiency and accuracy enables quick decisions about content and talent grounded in real performance data. It was founded in 2013 and headquartered in Seattle, Washington.
Cone & Steiner is a one-stop shop brimming indoors and out with fresh flowers and produce, dry goods, ice cream, and a curated selection of prepared foods. It features a unique twist on the corner store it features specialty, local, and staple goods, as well as a robust assortment of craft beers and fine wines.
ReelSonar, Inc. is a company that specializes in designing and developing innovative fishing technology. Its flagship product, the iBobber, is a castable fishfinder that utilizes sonar technology to locate fish at depths of up to 135 feet. The iBobber connects via Bluetooth to smartphones and tablets, allowing users to access various features such as GPS tagging of fishing hotspots, mapping waterbed contours, and monitoring water temperature. Additionally, the application includes functionalities like lunar calendar information, weather updates, Trip Logs, and Fish and Bite Alarms, enhancing the fishing experience. ReelSonar offers its products through various retail channels and online, serving customers in the United States, Canada, Europe, Asia, and beyond. Founded in 2012 and headquartered in Seattle, Washington, ReelSonar aims to improve fishing efficiency and enjoyment for anglers of all levels.
Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, that focuses on enhancing cancer surgery through innovative technologies. Founded in 2010, the company develops tumor paint products, including its lead candidate, BLZ-100, which combines a targeting peptide with a fluorescent dye. This product enables real-time visualization of cancer cells during surgery, allowing surgeons to differentiate between tumors and healthy tissue more effectively. The technology is applicable to various solid tumor types, including brain, breast, prostate, lung, colorectal, skin, and sarcomas. By improving the detection of cancer cells, Blaze Bioscience aims to facilitate more precise surgical resections and ultimately enhance patient outcomes.
Monitor Mask Inc. is a Seattle-based medical device company that specializes in manufacturing and selling face mask solutions designed for CO2 sampling in sidestream capnography, particularly during sedation anesthesia. Founded in 2012, the company primarily serves hospitals and ambulatory surgery centers, catering to various medical environments such as operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. The initial product, the M1 Capnography Mask, inspired the development of the CapnoVue face mask series, which aims to enhance patient safety and streamline clinical workflows. As of May 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.
Tether Technologies, Inc. specializes in preemptive key loss technology aimed at enhancing security for individuals and businesses while preventing key loss incidents and their associated costs. The company's flagship product, the electronic key tether (ekt), preemptively locates keys before they are lost and ensures they remain within a 15-step radius of the user. This innovative solution is designed to integrate seamlessly into existing key control programs and is suitable for various sectors, including security, property management, hospitality, healthcare, and law enforcement. Founded in 2010 and headquartered in Seattle, Washington, Tether Technologies offers a reliable and scalable alternative to traditional key management systems, which often respond only after keys are lost, leading to expensive rekeying processes and potential security breaches.
KPI Therapeutics, Inc. is a Seattle-based company focused on developing therapies for unmet medical needs in autoimmunity and chronic pain. Founded in 2013, it specializes in creating drug candidates such as dalazatide, KPI-150, and KPI-190 for systemic autoimmune diseases like lupus, along with CSP conopeptide for chronic pain management. The company collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance its research and development efforts. KPI Therapeutics aims to accelerate the progression of promising drug candidates through the critical translational stage of development, ultimately improving access to innovative treatments for patients.
Monitor Mask Inc. is a Seattle-based medical device company that specializes in manufacturing and selling face mask solutions designed for CO2 sampling in sidestream capnography, particularly during sedation anesthesia. Founded in 2012, the company primarily serves hospitals and ambulatory surgery centers, catering to various medical environments such as operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. The initial product, the M1 Capnography Mask, inspired the development of the CapnoVue face mask series, which aims to enhance patient safety and streamline clinical workflows. As of May 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.
Private Equity Round in 2015
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound medical devices for diagnosing middle ear infections, known as otitis media, in both children and adults. The company's innovative hand-held device enables clinicians to quickly and accurately distinguish between viral and bacterial infections, facilitating appropriate treatment decisions regarding antibiotic use. Utilizing ultrasound technology in a novel manner, the device offers rapid diagnostic results in seconds, making it user-friendly for both physicians and non-physician healthcare providers. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies aims to improve the efficiency and accuracy of middle ear infection diagnosis.
KPI Therapeutics, Inc. is a Seattle-based company focused on developing therapies for unmet medical needs in autoimmunity and chronic pain. Founded in 2013, it specializes in creating drug candidates such as dalazatide, KPI-150, and KPI-190 for systemic autoimmune diseases like lupus, along with CSP conopeptide for chronic pain management. The company collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance its research and development efforts. KPI Therapeutics aims to accelerate the progression of promising drug candidates through the critical translational stage of development, ultimately improving access to innovative treatments for patients.
Kineta, Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing immunology-based therapies targeting oncology, neuroscience, and virology. The company is advancing several innovative treatments, including KCP-506, a non-opioid therapeutic for chronic pain, and LHF-535, an oral antiviral for Lassa and other arenaviruses, which works by inhibiting viral entry and replication. Additionally, Kineta is exploring RIG-I and VISTA drug development programs aimed at reprogramming the immune system to combat cancer. Founded in 2007, Kineta has established strategic partnerships with major pharmaceutical firms to enhance its research and development efforts.
Tether Technologies, Inc. specializes in preemptive key loss technology aimed at enhancing security for individuals and businesses while preventing key loss incidents and their associated costs. The company's flagship product, the electronic key tether (ekt), preemptively locates keys before they are lost and ensures they remain within a 15-step radius of the user. This innovative solution is designed to integrate seamlessly into existing key control programs and is suitable for various sectors, including security, property management, hospitality, healthcare, and law enforcement. Founded in 2010 and headquartered in Seattle, Washington, Tether Technologies offers a reliable and scalable alternative to traditional key management systems, which often respond only after keys are lost, leading to expensive rekeying processes and potential security breaches.